HER-3 targeting alters the dimerization pattern of ErbB protein family members in breast carcinomas-Reference-Cited by-同舟云学术

HER-3 targeting alters the dimerization pattern of ErbB protein family members in breast carcinomas

Published:2015-12-26 Issue:5 Volume:7 Page:5576-5597
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Karamouzis Michalis V.¹,Dalagiorgou Georgia¹,Georgopoulou Urania²,Nonni Afroditi³,Kontos Michalis⁴,Papavassiliou Athanasios G.¹

Affiliation:

1. Molecular Oncology Unit, Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece

2. Laboratory of Molecular Virology, Hellenic Pasteur Institute, 11521 Athens, Greece

3. First Department of Pathology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece

4. Department of Propaedeutic Surgery, Medical School, National and Kapodistrian University of Athens, ‘Laikon’ General Hospital, 11527 Athens, Greece

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resistance to hormone therapy in breast cancer cells promotes autophagy and EGFR signaling pathway;American Journal of Physiology-Cell Physiology;2023-09-01

2. Switchable DNA Catalysts for Proximity Labeling at Sites of Protein–Protein Interactions;Journal of the American Chemical Society;2023-07-18

3. HER2 inhibition increases non-muscle myosin IIA to promote tumorigenesis in HER2+ breast cancers;PLOS ONE;2023-05-18

4. Potential clinically useful prognostic biomarkers in triple-negative breast cancer: preliminary results of a retrospective analysis;Breast Cancer: Targets and Therapy;2018-11

5. Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4–1 and NRDP1, in primary breast cancer;BMC Cancer;2018-10-26